Jazz Pharmaceuticals plc (JAZZ)
NASDAQ·Healthcare·Biotechnology
$202.85
+0.81%
Mkt Cap $12.25B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | $1.17B | $1.20B | +2.81% | $6.52 | $6.64 | +1.84% | — | — |
| Q4 2025 Nov 5, 2025 | $1.11B | $1.13B | +1.35% | $5.95 | $8.13 | +36.64% | — | — |
| Q3 2025 Aug 5, 2025 | $1.05B | $1.05B | -0.14% | -$6.12 | -$8.25 | -34.80% | — | — |
| Q2 2025 May 6, 2025 | $1.06B | $897.84M | -15.68% | $4.51 | $1.68 | -62.75% | — | — |
| Q1 2025 Feb 25, 2025 | $984.98M | $1.09B | +10.48% | $5.83 | $6.60 | +13.21% | — | — |
| Q4 2024 Nov 6, 2024 | $1.06B | $1.05B | -0.18% | $5.47 | $6.61 | +20.84% | — | — |
| Q3 2024 Jul 31, 2024 | $1.04B | $1.02B | -1.34% | $4.68 | $5.30 | +13.25% | — | — |
| Q2 2024 May 1, 2024 | $953.97M | $901.98M | -5.45% | $4.14 | $2.68 | -35.27% | — | — |
| Q1 2024 Feb 28, 2024 | $957.25M | $1.01B | +5.71% | $5.26 | $5.02 | -4.56% | — | — |
| Q4 2023 Nov 8, 2023 | $1.01B | $972.14M | -3.63% | $4.90 | $4.84 | -1.22% | — | — |
| Q3 2023 Aug 9, 2023 | $942.86M | $957.32M | +1.53% | $4.46 | $4.51 | +1.12% | — | — |
| Q2 2023 May 10, 2023 | $943.94M | $892.81M | -5.42% | $4.26 | $3.95 | -7.28% | — | — |
| Q1 2023 Mar 1, 2023 | $895.37M | $972.12M | +8.57% | $0.51 | -$0.07 | -113.73% | — | — |
| Q4 2022 Nov 9, 2022 | $939.98M | $940.65M | +0.07% | $4.72 | $5.17 | +9.53% | — | — |
| Q3 2022 Aug 3, 2022 | $902.49M | $932.88M | +3.37% | $4.20 | $4.30 | +2.38% | — | — |
| Q2 2022 May 4, 2022 | $852.45M | $813.72M | -4.54% | $3.75 | $3.73 | -0.53% | — | — |
| Q1 2022 Mar 1, 2022 | $864.30M | $896.73M | +3.75% | $3.71 | $4.21 | +13.48% | — | — |
| Q4 2021 Nov 9, 2021 | $834.83M | $838.12M | +0.39% | $3.27 | $4.20 | +28.44% | — | — |
| Q3 2021 Aug 3, 2021 | $751.81M | $751.81M | +0.00% | $3.55 | $3.90 | +9.86% | — | — |
| Q2 2021 May 4, 2021 | $610.74M | $607.58M | -0.52% | $3.69 | $3.92 | +6.23% | — | — |